search
for
 About Bioline  All Journals  Testimonials  Membership  News


Journal of Postgraduate Medicine
Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
ISSN: 0022-3859
EISSN: 0022-3859
Vol. 51, No. 1, 2005, pp. 68-71
Bioline Code: jp05023
Full paper language: English
Document type: Research Article
Document available free of charge

Journal of Postgraduate Medicine, Vol. 51, No. 1, 2005, pp. 68-71

 en Drug Review - Insulin glargine: A long acting insulin analog
Chakkarwar P.N., Manjrekar N.A.

Abstract

The main goal of treatment of diabetes mellitus (DM) is to maintain long term near normoglycemia. Insulin therapy plays a pivotal role in the management of DM. Most insulin preparations and insulin delivery systems, do not mimic the physiological insulin secretion in the body, leading to impaired metabolic ocntrol and increased hypoglycemic attacks. Insulin glargine is newer, long acting insulin analog with duration of action of 24 hr. It better efficacy than the currently used insulin replacement therapies with no increased side effects. In the surrent scenario, thought it is difficult to achieve an ideal insulin replacement therapy, insulin glargine is definitely a positive step in theat direction.

Keywords
Diabetes mellitus, newer insiulin, peak lsess insulin

 
© Copyright 2005 Journal of Postgraduate Medicine.
Alternative site location: http://www.jpgmonline.com

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil